Clinical Trial Update: Pegylated Recombinant Human Arginase 1 in Combination With Oxaliplatin and Capecitabine for the Treatment of HCC [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating pegylated recombinant human arginase 1 in combination with oxaliplatin and capecitabine for hepatocellular carcinoma has completed. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Capecitabine (capecitabine)
• OXALIPLATIN (Oxaliplatin)
• Pegylated Recombinant Human Arginase 1

Snippet

Sponsor: Bio-Cancer Treatment International Limited | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: COMPLETED